Heritability of renal function in hypertensive families of African descent in the Seychelles (Indian Ocean)  by Bochud, Murielle et al.
Kidney International, Vol. 67 (2005), pp. 61–69
Heritability of renal function in hypertensive families of African
descent in the Seychelles (Indian Ocean)
MURIELLE BOCHUD, ROBERT C. ELSTON, MARC MAILLARD, PASCAL BOVET, LAURENT SCHILD,
CONRAD SHAMLAYE, and MICHEL BURNIER
Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, Ohio; Division d’Hypertension et de
Me´decine Vasculaire et Division de Ne´phrologie, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland; Institut
Universitaire de Me´decine Sociale et Pre´ventive, Lausanne, Switzerland; Unit for Prevention and Control of Cardiovascular
Disease, Ministry of Health, Seychelle; Institut de Pharmacologie et de Toxicologie, Universite´ de Lausanne, Switzerland; and
Ministry of Health, The Republic of Seychelles
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descent in the Seychelles (Indian Ocean).
Background. We estimated the heritability of three measures
of glomerular filtration rate (GFR) in hypertensive families of
African descent in the Seychelles (Indian Ocean).
Methods. Families with at least two hypertensive siblings and
an average of two normotensive siblings were identified through
a national hypertension register. Using the ASSOC program in
SAGE (Statistical Analysis in Genetic Epidemiology), the age-
and gender-adjusted narrow sense heritability of GFR was esti-
mated by maximum likelihood assuming multivariate normality
after power transformation. ASSOC can calculate the additive
polygenic component of the variance of a trait from pedigree
data in the presence of other familial correlations. The effects
of body mass index (BMI), blood pressure, natriuresis, along
with sodium to potassium ratio in urine and diabetes, were also
tested as covariates.
Results. Inulin clearance, 24-hour creatinine clearance, and
GFR based on the Cockcroft-Gault formula were available for
348 persons from 66 pedigrees. The age- and gender-adjusted
correlations (± SE) were 0.51 (± 0.04) between inulin clearance
and creatinine clearance, 0.53 (± 0.04) between inulin clearance
and Cockcroft-Gault formula and 0.66 (± 0.03) between cre-
atinine clearance and Cockcroft-Gault formula. The age- and
gender-adjusted heritabilities (± SE) of GFR were 0.41 (± 0.10)
for inulin clearance, 0.52 (± 0.13) for creatinine clearance, and
0.82 (± 0.09) for Cockcroft-Gault formula. Adjustment for BMI
slightly lowered the correlations and heritabilities for all mea-
surements whereas adjustment for blood pressure had virtually
no effect.
Conclusion. The significant heritability estimates of GFR in
our sample of families of African descent confirm the familial
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aggregation of this trait and justify further analyses aimed at
discovering genetic determinants of GFR.
High blood pressure is a strong and independent risk
factor for end-stage renal disease (ESRD) in industrial-
ized countries [1, 2]. For example, men with severe hy-
pertension (systolic pressure ≥210 mm Hg or diastolic
pressure ≥120 mm Hg) had a 22-fold increased risk of
developing ESRD over men with optimal blood pressure
levels (systolic pressure <120 mm Hg and diastolic pres-
sure <80 mm Hg) in the MRFIT study [1]. Although few
data are available, hypertension appears to be an impor-
tant public health problem and a major cause of ESRD
in African countries as well, with hypertension affect-
ing about 20% of the adult population [3]. Unravelling
genes controlling renal function is particularly important
among individuals of African ancestry with, or suscep-
tible to, essential hypertension because of their known
propensity to develop ESRD [4–10].
Techniques available to determine glomerular filtra-
tion rate (GFR) have been described previously [11, 12].
Although the inulin clearance is the accepted gold stan-
dard, the endogenous creatinine clearance, formulas such
as the Cockcroft-Gault [13] or the Modification of Diet
in Renal Disease (MDRD) [14] formulas are more com-
monly used in clinical practice.
With one exception [15], several previous studies have
suggested an important role of genetic factors in deter-
mining GFR [16–18]. We are not aware of any study
reporting the heritability of inulin clearance, the gold
standard, in a large population. Moreover, the heritabil-
ity of renal function has never been assessed in African
pedigrees. Therefore, the purpose of this study was to
investigate and compare the heritabilities of three mea-
sures of GFR (inulin clearance, creatinine clearance, and
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Cockcroft-Gault formula) in families of African descent
in the Seychelles.
METHODS
Population and sampling
This report is of a secondary study conducted on a sam-
ple of families collected prospectively for the primary
purpose of a candidate gene study of hypertension. The
study took place in the Seychelles Islands, which lie ap-
proximately 1000 km east of Kenya and 1000 km north of
Madagascar and Mauritius. The Seychelles Islands, which
were first colonized in the late 1700s, are populated pre-
dominantly by individuals of East African descent. Two
previous population surveys showed a high prevalence of
hypertension in the adult population [19, 20]. Health care
is delivered through a national health system. Medical
care and treatment are free of charge to all inhabitants.
Families were selected from an ongoing national regis-
ter that includes all patients with hypertension who at-
tend primary health care centers. We used a convenience
sampling strategy. The identification of eligible families
relied on the presence of two or more persons with the
same family name in the register as well as on informa-
tion about eligible persons as provided by nurses working
in the health centers attended by these eligible individu-
als. Families were selected if there were two or more full
siblings with hypertension (defined as being on current
antihypertensive treatment or having a systolic and/or
diastolic blood pressure ≥140/90 mm Hg based on the av-
erage of six office readings obtained on a single day) and
two or more other first-degree relatives (full siblings or
parents), irrespective of their hypertension status. Partic-
ipants were recruited from July 1999 until January 2002.
Four hundred and ninety-four subjects participated in the
primary study and 357 had all three GFR measures avail-
able. Three of the 357 subjects had missing off-treatment
office blood pressure values. We also excluded six indi-
viduals with extreme outlier values for GFR (i.e., obser-
vations lying three interquartile ranges beyond the first
and third quartiles) from the remaining 354, leaving 348
individuals for the analyses. There were 66 one- or two-
generation families with GFR measures (i.e., 348 partic-
ipants from 77 sibships). Forty-seven families comprised
one generation and 19 comprised two generations. The
average sibship size (± SD) was 4.3 (± 1.7), the aver-
age number of normotensive siblings was 2.0 (± 1.8), and
the average number of parents with data per sibship was
0.35 (± 0.05). We also conducted additional analyses on
participants with available daytime ambulatory blood
pressure (i.e., 330 participants) on the 314 nondiabetic
participants and on participants above the gender-specific
20th percentile of urinary creatinine excretion (i.e., 280
participants with a creatininuria>0.115 mmol/kg/24-hour
for men and >0.112 mmol/kg/24-hour for women) as a
proxy for ensuring completeness of the urinary collec-
tion. All participants were aged 18 years or older, were
born in the Seychelles Islands, and gave their written
informed consent. The study protocol was approved by
the Ethical Committees of the Ministry of Health in the
Seychelles and of the Faculty of Medicine of the Univer-
sity of Lausanne (Switzerland).
Body mass index (BMI) and blood pressure
Weight was measured using an electronic scale cali-
brated to the nearest 0.1 kg on participants without shoes
and only wearing underwear, and height was measured
to the nearest 0.5 cm using a wall-mounted stadiometer.
BMI was calculated as weight (kg) divided by squared
height (m2). Daytime ambulatory blood pressure was
measured using Diasys devices (Diasys Integra, Novacor
SA, Rueil-Malmaison, France) placed on the left arm
with an appropriately sized cuff. Measurements were
based on the auscultatory mode, relayed by the oscillo-
metric mode in case of failure of the auscultatory mode,
and were recorded every 20 minutes. Daytime ambula-
tory blood pressure in this study is the average of the first
ten valid readings between 7:00 a.m. and the patient’s
self-reported bedtime. We considered as invalid values:
systolic blood pressure <50 mm Hg or >250 mmHg; di-
astolic blood pressure <30 mm Hg or >150 mmHg; pulse
pressure (systolic blood pressure − dialstolic blood pres-
sure) <10 mm Hg or >150 mmHg; and pulse <35 beats/
min or >250 beats/min. In total, 0.6% of the ambulatory
blood pressure values were invalid and discarded. Office
blood pressure was measured in a sitting position using
a standard mercury sphygmomanometer with a cuff that
automatically adapts the bladder to arm circumference
(TriCuff, Stockholm, Sweden) in subjects who had been
quiet for at least 10 minutes. Triplicate measurements on
two consecutive mornings after a 2-week washout period
off-treatment were averaged. The mean ambulatory and
office blood pressure was defined as (2/3) diastolic blood
pressure + (1/3) systolic blood pressure.
Clearance procedures and laboratory measurements
Antihypertensive therapy, if any, was stopped for
2 weeks before starting the protocol. After this washout
period, participants were requested to collect urine by
voluntarily voiding during 24 hours while on their usual
diet, to measure sodium, potassium, and creatinine ex-
cretions. Creatinine clearance was based on this 24-hour
urine collection. After overnight fasting, on the day fol-
lowing the 24-urine collection clearance protocols began
between 7:00 a.m. and 8:00 a.m. in a quiet room with
the subject lying on a bed throughout the procedure ex-
cept for active voiding. Two intravenous catheters were
inserted into antecubital veins, one for the infusion of
inulin and the second into the contralateral forearm for
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blood drawing. Fasting blood samples were collected first.
After an oral water load of 200 mL, a bolus and a follow-
ing sustained infusion of inulin, which were adapted to
the participant’s height, weight, and gender, were given
to ensure a stable plasma concentration as described pre-
viously [21]. Participants received 400 mL of oral water at
time 60 minutes and thereafter 200 mL every hour. After a
2-hour equilibration period, two 1-hour inulin clearances
were obtained to measure GFR. The inulin and 24-hour
creatinine clearances (Cx) were calculated with the for-
mula Cx = Ux∗V/Px, where Ux and Px are urinary and
plasma concentrations of the × solute, and V is the urine
flow rate in mL/min. We also calculated GFR using the
Cockcroft-Gault formula: creatinine clearance = {[(140-
age[yr]) × weight[kg]/72]/plasma creatinine [mg/dL]}×
s, where s = 1 for males and 0.85 for females [13].
Urinary and plasma sodium and potassium concen-
trations were measured by flame photometry (IL-943)
(Instrumentation Laboratory, Milano, Italy) and crea-
tinine concentration was measured by the picric acid
method (Cobas-Mira; Roche, Basel, Switzerland). Uri-
nary and plasma concentrations of inulin were deter-
mined by photometry (Autoanalyzer II-Technicon; Bran
& Luebbe, Norderstedt, Germany). Participants on an-
tidiabetic treatment during the preceding month or with
fasting blood glucose ≥7.0 mmol/L (measured using a
Glycotronic C reflectometer; Macherey-Nagel, Du¨ren,
Germany) were considered as diabetics. Untreated par-
ticipants were considered as diabetic only if a second
test confirmed the first result of a fasting blood glucose
>7 mmol/L. None of the 15 newly diagnosed (hence un-
treated) out of a total of 34 diabetic participants had a
second test below 7.1 mmol/L.
Statistical analyses
Heritability is a measure of familial resemblance which
rests on the assumption that the total phenotypic variance
of a quantitative trait can be partitioned into indepen-
dent genetic and environmental components. In turn, the
genetic variance can be divided into an additive genetic
variance, a dominance variance and an epistatic vari-
ance. Additive variance represents the average effects
of individual alleles on the trait and reflects transmissible
resemblance between relatives. Dominance variance rep-
resents the nonlinear interaction effects between alleles
at the same locus while epistatic variance represents in-
teraction effects between alleles at different loci. Heri-
tability in the narrow sense is defined as the ratio of the
additive genetic variance to the total phenotypic vari-
ance [22]. In this paper we refer to “heritability in the
narrow sense” simply as heritability. Estimating the her-
itability of a trait is one of the first steps in the gene-
finding process. To estimate heritability we used a linear
regression model in which the total residual variance is
partitioned, after regressing on covariates, into the sum
of an additive polygenic component, a sibling component
and an individual-specific random component. Heritabil-
ity was estimated as the polygenic component divided by
the total residual variance. We estimated the heritabil-
ity of the three GFR measures, inulin clearance, crea-
tinine clearance, and Cockcroft-Gault formula, as well
as of plasma creatinine for comparison with Cockcroft-
Gault formula. Age, gender, BMI, diabetes status, along
with diabetes duration, 24-hour natriuresis and urinary
sodium to potassium ratio (Na/K) and mean blood pres-
sure (both office and ambulatory) were used as covari-
ates. Continuous covariates were standardized for the
analyses. We used the ASSOC program in Statistical
Analysis in Genetic Epidemiology (SAGE), so named
because it estimates from family data association param-
eters (regression coefficients). ASSOC implements max-
imum likelihood estimation of both the components of
variance and covariate coefficients, on the assumption
of multivariate normality of the residuals but allowing
for a Box-Cox transformation [23] of both sides of the
regression equation [24], simultaneously estimating the
power parameter. Allowing for a transformation relaxes
the usual strict assumption of normality, and transforma-
tion of both sides results in median-unbiased estimates
of the covariate coefficients on the original scale of mea-
surement. All models were analyzed with and without a
common sibship component, which can represent either a
dominance component or a common sibship environmen-
tal component. Correlation coefficients between inulin
clearance, creatinine clearance, and Cockcroft-Gault for-
mula (each with covariate adjustments calculated from
the coefficients estimated using ASSOC) were consis-
tently estimated using all pairs of relatives of a partic-
ular type, as implemented in the Family CORrelations
(FCOR) program in SAGE, with their standard errors
calculated allowing for all pedigree relationships. This
program does not make any distributional assumptions,
but computes standard errors using only the large sam-
ple properties of the sums of squares and cross-products
[25]. The genetic (polygenic) correlations between pairs
of GFR measurements (i.e., inulin clearance-creatinine
clearance, inulin clearance-Cockcroft-Gault formula, and
creatinine clearance-Cockcroft-Gault formula) were es-
timated using the formula:
qpolygenic = Cov(Xadj, Yadj)√
Vp(Xadj)Vp(Yadj)
where Vp (X adj) and Vp (Y adj) represent the polygenic
variances of the adjusted residuals of traits X and Y and
Cov(X adj,Y adj) is the polygenic covariance.
RESULTS
The characteristics of the participants are listed in
Table 1. Overall, the average creatinine clearance was
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Table 1. Participant characteristics
All Complete UC Not complete UC
(N = 348) (N = 280) (N = 68)
estimate (SE) estimate (SE) estimate (SE) P valuea
Gender % female 0.56 (0.03) 0.56 (0.03) 0.56 (0.06) 0.98
Age years 46.2 (0.9) 45.0 (0.7) 51.1 (1.5) 0.0001
Body mass index kg/m2 27.8 (0.3) 27.4 (0.3) 29.7 (0.7) 0.001
Office blood pressure (off-treatment) mm Hg
Systolic 133.3 (1.0) 132.4 (1.1) 137.4 (1.1) 0.06
Diastolic 85.4 (0.6) 84.9 (0.7) 87.3 (1.4) 0.14
Mean 101.4 (0.7) 100.7 (0.8) 104.0 (1.7) 0.08
Daytime ambulatory blood pressureb mm Hg
Systolic 134.4 (0.9) 133.7 (1.0) 137.1 (2.4) 0.17
Diastolic 88.1 (0.7) 87.5 (0.7) 90.4 (1.5) 0.09
Mean 103.5 (0.7) 102.9 (0.8) 106.0 (1.7) 0.10
Fasting blood glucose mmol/L 4.7 (0.1) 4.6 (0.1) 5.3 (0.3) 0.01
Diabetesc % diabetics 9.8 (1.6) 8.9 (1.7) 13.2 (4.1) 0.28
Diabetes durationd years 4.6 (0.9) 4.7 (1.1) 4.7 (1.1) 0.77
Plasma mmol/L
Sodium 140.1 (0.2) 140.1 (0.2) 140.1 (0.5) 0.95
Potassium 3.75 (0.02) 3.74 (0.01) 3.75 (0.04) 0.85
Creatinine 76.8 (0.9) 77.1 (1.1) 75.3 (1.9) 0.41
Urinary (24-hour) mmol/24 hours
Sodium 107 (3) 114 (3) 79 (5) <0.0001
Potassium 44 (1) 46 (1) 34 (3) <0.0001
Creatinine 12.4 (0.2) 13.2 (0.2) 8.9 (0.3) <0.0001
Inulin clearance 116 (2) 115 (2) 118 (5) 0.60
Creatinine clearance (24-hour) mL/min 113 (2) 120 (2) 83 (3) <0.0001
GFR calculated using Cockcroft-Gault formula mL/min 109 (2) 108 (2) 112 (5) 0.36
Abbreviations are: GFR, glomerular filtration rate; Complete UC, urinary creatinine excretion above the gender-specific 20th percentile (0.154 mmol/kg/24 hours
for men and 0.112 mmol/kg/24 hours for women).
aP values for the differences between the creatininuria groups were calculated using a t test for continuous variables and a chi-square test for categorical variables.
bAverage of the 10 first valid measures.
cOn antidiabetic treatment or having a fasting blood glucose >7 mmol/L.
dFor diabetic participants only. Results are given as mean (SE) unless stated otherwise.
slightly lower than the inulin clearance, but if the analy-
sis was restricted to the 280 participants with a 24-hour
creatininuria above the 20th percentile, which suggests a
more complete 24-hour urine collection, the average cre-
atinine clearance was 4% higher than the average inulin
clearance. Women (not shown) had significantly higher
BMI than men (28.8 vs. 26.6 kg/m2) (P = 0.0002), longer
duration of diabetes (6.7 vs. 3.1 years) (P = 0.04),
lower plasma potassium (3.7 vs. 3.8 mmol/L) (P = 0.001),
lower creatinine (70.4 vs. 84.8 lmol/L) (P < 0.0001), lower
urinary creatinine excretion (10.4 vs. 14.9 mmol/24-hour)
(P < 0.0001), lower inulin clearance (109 vs. 123 mL/min)
(P = 0.0003), and lower creatinine clearance (105 vs.
123 mL/min) (P < 0.0001). Urinary electrolyte excretions
and Cockcroft-Gault formula were similar for men and
women.
Unadjusted and adjusted (for various covariates) cor-
relations are presented in Table 2. Overall correlations
were moderate, ranging from 0.44 to 0.81. The high-
est correlations were seen between creatinine clear-
ance and Cockcroft-Gault formula, while both creatinine
clearance and Cockcroft-Gault formula correlated less
strongly with inulin clearance. Adjustment for age and
gender slightly lowered inulin clearance-Cockcroft-Gault
formula and creatinine clearance-Cockcroft-Gault for-
mula correlations, but not the inulin clearance-creatinine
clearance correlation. The other adjustments made only
small changes to the correlations. Inulin clearance-
creatinine clearance correlations as well as creatinine
clearance-Cockcroft-Gault formula correlations were
one to three standard errors higher for those partici-
pants with a complete urine collection as compared to the
whole sample, whereas inulin clearance-Cockcroft-Gault
formula correlations are about one standard error lower
for this subgroup. The age- and gender-adjusted correla-
tions (se) between plasma creatinine and inulin clearance,
creatinine clearance, and Cockcroft-Gault formula were
0.08 (0.06), −0.03 (0.06), and −0.29 (0.06), respectively.
The parent-offspring correlations ranged from 0.19 to
0.25 for inulin clearance, from 0.03 to 0.08 for creatinine
clearance, and from 0.06 to 0.19 for Cockcroft-Gault for-
mula (Table 3). The sibling correlations ranged from 0.07
to 0.13 for inulin clearance, from 0.12 to 0.21 for creati-
nine clearance, and from 0.26 to 0.42 for Cockcroft-Gault
formula. The sibling correlations restricted to the 280 in-
dividuals with a more complete urine collection were one
standard error higher than for the whole sample for cre-
atinine clearance but not for either inulin clearance or
Cockcroft-Gault formula. Because of their large standard
errors (due to the small number of parent-offspring pairs
in our sample), the parent-offspring correlations are of
limited usefulness.
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Table 2. Unadjusted and adjusted correlations between glomerular filtration rate (GFR) measures for the whole sample and the subgroup with
complete urine collection
Inulin clearance- Inulin clearance- Creatinine clearance-
creatine clearance Cockcroft-Gault formula Cockcroft-Gault formula
Adjustment All Complete UC All Complete UC All Complete UC
Unadjusted 0.49 (0.05) 0.54 (0.05) 0.56 (0.04) 0.53 (0.05) 0.73 (0.03) 0.81 (0.03)
Age and gender 0.51 (0.04) 0.56 (0.04) 0.53 (0.04) 0.49 (0.05) 0.66 (0.03) 0.75 (0.03)
Age, gender, and BMI 0.49 (0.04) 0.52 (0.04) 0.51 (0.04) 0.44 (0.05) 0.67 (0.03) 0.75 (0.03)
Age, gender, and diabetesa 0.47 (0.04) 0.53 (0.05) 0.50 (0.04) 0.46 (0.05) 0.65 (0.04) 0.73 (0.03)
Age, gender, and office blood pressureb 0.48 (0.04) 0.54 (0.04) 0.51 (0.04) 0.47 (0.05) 0.65 (0.03) 0.74 (0.03)
Age, gender, natriuresis, and urine Na/K 0.51 (0.04) 0.56 (0.04) 0.53 (0.04) 0.49 (0.05) 0.66 (0.03) 0.74 (0.03)
BMI is body mass index.
aDiabetes includes both an indicator variable for diabetes (1) versus no diabetes (0), and a variable for the duration of diabetes.
bOff-treatment office blood pressure is used. Results are expressed as correlations (SE).
Table 3. Familial correlations for three glomerular filtration rate (GFR) measures
Covariates
Office mean Natriuresis and
None Body mass index Diabetes arterial pressure urine Na/K
Parent-offspring (all)
IC 0.25 (0.11) 0.19 (0.10) 0.20 (0.12) 0.25 (0.11) 0.25 (0.11)
CC 0.08 (0.10) 0.08 (0.09) 0.03 (0.11) 0.08 (0.10) 0.08 (0.10)
CGF 0.19 (0.14) 0.06 (0.12) 0.16 (0.14) 0.18 (0.14) 0.18 (0.14)
Parent-offspring (complete urine)
IC 0.26 (0.13) 0.18 (0.14) 0.19 (0.11) 0.25 (0.14) 0.26 (0.13)
CC 0.11 (0.15) 0.03 (0.13) 0.03 (0.14) 0.10 (0.15) 0.10 (0.15)
CGF 0.16 (0.16) −0.02 (0.14) 0.10 (0.15) 0.15 (0.15) 0.15 (0.16)
Sibling (all)
IC 0.12 (0.06) 0.07 (0.05) 0.11 (0.05) 0.13 (0.06) 0.12 (0.06)
CC 0.20 (0.06) 0.12 (0.06) 0.21 (0.06) 0.20 (0.06) 0.20 (0.06)
CGF 0.41 (0.07) 0.26 (0.07) 0.42 (0.07) 0.41 (0.07) 0.40 (0.07)
Sibling (complete urine)
IC 0.15 (0.07) 0.10 (0.06) 0.14 (0.07) 0.14 (0.07) 0.15 (0.07)
CC 0.27 (0.08) 0.18 (0.07) 0.31 (0.08) 0.27 (0.08) 0.28 (0.08)
CGF 0.37 (0.08) 0.24 (0.07) 0.37 (0.08) 0.37 (0.08) 0.36 (0.08)
Abbreviations are: IC, inulin clearance; CC, 24-hour creatinine clearance; CGF, GFR calculated using the Cockcroft-Gault formula. All traits were adjusted for age
and gender. Results are expressed as correlations (SE).
Age- and gender-adjusted heritabilities for all three
GFR traits, without additional covariates, were significant
at least at the 0.01 level, whether or not a sibling compo-
nent of variance was included in the model (Table 4). Her-
itabilities for inulin clearance (ranging from 0.31 to 0.42)
and creatinine clearance (ranging from 0.42 to 0.52) were
moderate, whereas Cockcroft-Gault formula heritability
(ranging from 0.52 to 0.85) was higher. Allowing for an
additional sibling correlation (i.e., a variance component
that is due to either a dominance component or a common
sibship environmental component) did not substantially
modify the heritability estimates for inulin clearance or
creatinine clearance because the sibship component of
variance was either estimated to be zero or was not sig-
nificant. However, it slightly decreased Cockcroft-Gault
formula heritability, without being significant at the 0.05
level. Unlike office blood pressure that did not affect heri-
tabilities when added as a covariate, BMI slightly lowered
heritabilities for all three GFR traits (but not for creati-
nine alone). Analyses using daytime ambulatory mean
blood pressure as a covariate yielded results similar to
those of office blood pressure (results not shown). The in-
clusion of natriuresis along with urine Na/K as covariates
had little impact on the estimated heritabilities. The inclu-
sion of diabetes [using both a dichotomous (diabetes sta-
tus) and a continuous (diabetes duration) variable] in the
model barely changed creatinine clearance heritabilities
but somewhat decreased inulin clearance and Cockcroft-
Gault formula heritabilities. Analyses restricted to non-
diabetic participants yielded heritabilities ranging from
0.24 to 0.32 for inulin clearance (i.e., up to one standard
error lower than for the whole sample), from 0.43 to 0.54
for creatinine clearance (i.e., from 0% to 15% of one
standard error lower than for the whole sample), and
from 0.69 to 0.85 for Cockcroft-Gault formula (i.e., from
9% to 50% of one standard error higher than for the
whole sample). Models without a sibship component us-
ing plasma creatinine instead of Cockcroft-Gault formula
gave lower heritabilites as compared to Cockcroft-Gault
formula, whereas the plasma creatinine models that
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Table 4. Heritabilities of three measures of glomerular filtration rate (GFR)
Covariates
None Body mass index Diabetesa Office mean arterial pressure Urine Na and Na/K
h2 (SE) k1b h2 (SE)[Int] k1 h2 (SE) [Int] k1 h2 (SE) [Int] k1 h2 (se) [Int] k1
IC With sibshipc 0.40 0.03 0.35 0.03 0.30 [0.31e,g] 0.07 0.39 0.05 0.36 0.06
(0.13) (0.11) (0.13) (0.14) (0.11)
Without sibshipc 0.41 0.03 0.35 [0.36e] 0.03 0.34 [0.34e,g] 0.07 0.42 0.06 0.37 [0.36e,h] 0.07
(0.10) (0.11) (0.10) (0.11) (0.10)
CC With sibship 0.52 0.22 0.42 0.29 0.50 0.23 0.52 0.24 0.48 0.15
(0.13) (0.13) (0.12) (0.13) (0.13)
Without sibship 0.52 0.22 0.42 [0.42d] 0.29 0.50 0.23 0.54 [0.52f] 0.25 0.48 0.15
(0.13) (0.13) (0.12) (0.13) (0.13)
CGF With sibship 0.72 −0.11 0.36 [0.52d] −0.02 0.56 −0.12 0.71 [0.72f] −0.10 0.68 [0.81h] −0.10
(0.17) (0.26) (0.25) (0.18) (0.18)
Without sibship 0.82 −0.09 0.66 [0.70d] −0.01 0.79 −0.08 0.83 [0.82f] −0.08 0.85 −0.09
(0.09) (0.10) (0.09) (0.09) (0.10)
Creatinine With sibship 0.33 0.23 0.36 0.25 0.69 [0.68e] 0.13 0.37 0.25 0.36 0.23
(0.34) (0.35) (0.23) (0.33) (0.32)
Without sibship 0.65 0.25 0.66 0.26 0.75 [0.74e] 0.13 0.65 0.25 0.65 0.26
(0.10) (0.11) (0.11) (0.10) (0.11)
Abbreviations are: [Int], terms in square brackets are heritability estimates from models with interaction terms; IC, inulin clearance; CC, 24-hour creatinine clearance;
CGF, GFR calculated using the Cockcroft-Gault formula. Results are expressed as heritabilities (SE). All traits were adjusted for age and sex.
aDiabetes includes both an indicator variable for diabetes (1) versus no diabetes (0), and a variable for the duration of diabetes.
bk1 is power parameter in the generalized modulus power transformation.
cWith/without sibship, including/not including in the model a sibship correlation over and above that expected for polygenic inheritance.
dSignificant age × body mass index interaction.
eSignificant age × gender interaction.
fSignificant age × office blood pressure interaction.
gSignificant age × diabetes status interaction.
hSignificant age × (urine Na), gender × (urine Na), age × (urine Na/K), and gender × (urine Na/K) interactions. Cut-off P value for significant interactions: 0.05. k1
and standard errors with and without interaction terms are similar.
included a sibship component did not maximize optimally
(i.e., the first derivatives of the log likelihoods were not
as close to zero as for the other models).
We analyzed all two-way interactions and found, in par-
ticular, significant age × gender and age × BMI interac-
tions. All interactions significant at the 0.05 level were
kept in the models and are listed in the notes for Table 4.
The only major change due to the inclusion of an interac-
tion term was a 40% increase in Cockcroft-Gault formula
heritability due to a significant age × BMI interaction.
The power transformation values (k1) (Table 4) indicate
that the appropriate transformation to help induce the as-
sumed normality of the residuals is roughly logarithmic
for inulin clearance and Cockcroft-Gault formula and a
fourth root for creatinine clearance.
The age- and gender-adjusted genetic correlations were
0.56 for inulin clearance-creatinine clearance, 0.14 for
inulin clearance-Cockcroft-Gault formula, and 0.48 for
creatinine clearance-Cockcroft-Gault formula. The age-,
gender- and BMI-adjusted genetic correlations were es-
timated to be −0.14 for inulin clearance-creatinine clear-
ance, −0.04 for inulin clearance-Cockcroft-Gault for-
mula, and 0.61 for creatinine clearance-Cockcroft-Gault
formula. The age-, gender- and diabetes-adjusted genetic
correlations were 0.55 for inulin clearance-creatinine
clearance, 0.88 for inulin clearance-Cockcroft-Gault for-
mula, and 0.18 for creatinine clearance-Cockcroft-Gault
formula. The age-, gender-, and off-treatment office
blood pressure-adjusted genetic correlations were 0.24
for inulin clearance-creatinine clearance, 0.23 for in-
ulin clearance-Cockcroft-Gault formula, and 0.24 for
creatinine clearance-Cockcroft-Gault formula. The age-
and gender-adjusted genetic correlations between plasma
creatinine and inulin clearance, creatinine clearance, and
Cockcroft-Gault formula were −0.75, −0.69, and −0.80,
respectively. That these correlations are high in magni-
tude indicates that to a certain extent any one of the three
GFR measures can be used to study the genes involved
in creatinine control.
DISCUSSION
We have demonstrated significant heritability esti-
mates for three methods of determining GFR, ranging
from 31% to 85%, in a sample of East African fami-
lies each containing at least two hypertensive members.
Considering inulin clearance as the gold standard, both
creatinine clearance and Cockcroft-Gault formula over-
estimate GFR heritability. Our study demonstrates
that there exists a familial aggregation of GFR in
Black African pedigrees, as was reported previously in
Caucasians and African Americans [16–18] but our re-
sults are the first to demonstrate such an association
with the use of inulin clearance. Our results also con-
firm the high heritability of GFR (63%) found in female
twin data in the United Kingdom (presumably from a
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predominantly Caucasian sample) when measured with
the Cockcroft-Gault formula [16] and the moderate her-
itabilities (ranging from 27% to 56%) of the creatinine
clearance found in 49 Utah pedigrees ascertained through
either early coronary heart disease death, stroke death, or
hypertension for a Caucasian population [18]. Although
our results do not provide information about which genes
or how many genes might be involved, they justify con-
ducting additional analyses to look for genes involved in
GFR control.
We have compared GFR heritabilities using three dif-
ferent measures, each of which suffers from different lim-
itations. It is well recognized that creatinine is not the
ideal marker to measure since creatinine is secreted into
the urine and this secretion increases as renal failure pro-
gresses. Nonetheless, these approaches are those com-
monly used in clinical trials and epidemiologic studies. In
addition, the fact that creatinine is not the ideal marker,
use of the 24-hour creatinine clearance is also limited
by the high risk of incomplete urine collection. In our
study, only a single 24-hour urinary collection was ob-
tained from each participant. In contrast to the clearance
techniques, the calculation of the Cockroft-Gault formula
does not rest on urine measurements. Thus, the formula
avoids the problem of incomplete urine collections. How-
ever, the Cockcroft-Gault formula relies very much on
body weight and acute weight gains or losses can lead to
erroneous estimation of GFR.
The impact of the limitations of each technique are il-
lustrated by the moderate correlations between the three
proxies used, particularly inulin clearance-creatinine
clearance and inulin clearance-Cockcroft-Gault formula.
The correlations between inulin clearance-creatinine
clearance and inulin clearance-Cockcroft-Gault formula
remained low even if we only considered participants for
whom very similar inulin clearances were obtained, and
for whom therefore a high quality result can be assumed,
which suggests that the true correlations are indeed low
in our sample. Analyses restricted to individuals with a
higher creatininuria yielded slightly higher correlations
involving creatinine clearance, which suggests that in-
complete urine collection affects, albeit modestly, these
correlations. A large discrepancy in terms of correlations
between various GFR measurements can also be found
in the literature and our correlations are comparable with
those of other studies [26–32].
Because all three measures indicate a significant GFR
heritability, we are confident that genetic factors involved
in GFR control can be identified in our sample. The ad-
dition of covariates tended to lower heritabilities, the
largest and most consistent effect across all three GFR
traits being observed with BMI. Although such a finding
might suggest a common genetic control between GFR
and BMI, further evidence of this is needed, as this effect
is only modest for inulin clearance, the gold standard. In
addition, the maximum effect is observed for Cockcroft-
Gault formula (and no effect is observed for creatinine
alone) and one might argue that controlling Cockcroft-
Gault formula for BMI is debatable because body weight
is part of both composite variables. The genetic correla-
tions were often low and varied a lot according to which
covariates were included in the model. These results sug-
gest that the three GFR traits only modestly share genetic
factors in common. For instance, the near-zero estimates
for the genetic correlations between inulin clearance and
Cockcroft-Gault formula and between inulin clearance
and creatinine clearance, when adjusted for BMI, sug-
gest that studies designed to identify loci influencing GFR
are likely to detect different loci if these surrogate mea-
sures are used instead of inulin clearance. In view of
these results, even though inulin clearance has a lower
heritability, it is a purer measure of GFR and we would
recommend using inulin clearance for a genetic study
on GFR.
Our sampling scheme via individuals with high blood
pressure is not recommended to estimate a population
heritability. However, the fact that the heritability esti-
mates hardly changed after adjusting for off-treatment
office or ambulatory blood pressure, the trait on which the
families were ascertained, suggests that these estimates
are nevertheless appropriate for the general Seychelles
population. We acknowledge that, in terms of generaliz-
ability of the findings, such a correction is an imperfect
proxy for random sampling from the general population
or for conditioning the likelihood on the exact ascertain-
ment event, which would have been very difficult, given
the criteria of at least two hypertensive siblings (i.e., mul-
tiplex ascertainment).
The fact that inulin clearance and creatinine clearance
heritabilities were similar, with or without the inclusion
of a sibship component in the model, is compatible with
no significant departure from an additive genetic model.
On the other hand, the effect of the sibship compo-
nent on heritabilities was slightly more pronounced for
Cockcroft-Gault formula and highest for plasma creati-
nine. As plasma creatinine models with a sibship com-
ponent did not maximize adequately, we suspect that the
lower Cockcroft-Gault formula heritabilities when a sib-
ship component was estimated are due to the creatinine
included in the Cockcroft-Gault formula. Because we ad-
justed for some of the covariates that are part of the
Cockcroft-Gault formula, we also analyzed plasma crea-
tinine to facilitate interpretating the results. Note that the
sibship effect can, however, also partly be due to either a
dominance component, a common sibship environmental
component, or both.
Several caveats about the concept of heritability de-
serve mention. First, as in any ratio, factors that influence
either the numerator or the denominator will change her-
itability. Second, heritability being a population concept,
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our estimates only apply to the Seychelles Islands. Third,
several assumptions underlie the concept of heritability,
such as random mating and the absence of genotype-
environment interaction. Statistical interaction between
two variables can depend on their scale of measurement
and can often be removed by an appropriate transforma-
tion. Although we cannot exclude genotype-environment
interactions, their effects are minimized by the choice of
an appropriate scale of measurement, which we achieved
by simultaneously estimating that scale (the power trans-
formation) under a model that assumed no such in-
teractions. As mentioned above, the similar heritability
estimates obtained for inulin clearance and creatinine
clearance, regardless of the presence of a sibship corre-
lation, point toward no genetic dominance variance of
GFR. Finally, the individual-specific random component
of variance includes measurement error in addition to
other more strictly environmental influences. The low in-
tertrait correlations obtained between traits that measure
the same entity illustrate the potential degree of mea-
surement error for the determination of GFR, but do not
allow quantifying this error. Keeping all these limitations
in mind, the presence of a nonzero heritability remains
a necessary, although not sufficient, condition for the de-
tection of genes controlling GFR.
Although heritability has often been estimated from
samples of twins, the twin method is based on several
assumptions, the most fundamental of which are that
monozygotic and dizygotic twin pairs differ in their sim-
ilarities as a result of only genetic causes, and that both
types of twins and singletons have the same genotypic and
environmental population variances [33]. There is good
evidence that the former assumption often does not hold,
as monozygotic twins have been shown, for instance, to
be more similar than dizygotic twins for several demo-
graphic and lifestyle factors [34]. With regard to the latter
assumption, the majority of monozygotic twins are mono-
chorionic, who have on average a lower birth weight and
a higher perinatal mortality than dichorionic dizygotic
twins [35, 36]. In addition, monochorionic monozygotic
twins are characterized by placental anastomoses, which
can lead (in up to 30% of cases) to twin-twin transfu-
sion syndrome and subsequent renal tubular dysgenesis
[37]. Although we did not identify any study evaluating
the impact of chorionicity on long-term renal function,
the impact of low birth weight, which preferentially af-
fects monochorionic monozygotic twin, as a risk factor
for high blood pressure, has been extensively described
[38, 39]. Such findings raise the question of how heritabil-
ity, in general, and heritability of blood pressure-related
phenotypes such as GFR, in particular, calculated in twins
can be generalized to singletons. We therefore consider
our family-based approach to be a more appropriate and
more valid way to estimate GFR heritability than a twin-
based method.
CONCLUSION
The significant heritability estimates of GFR, as mea-
sured by inulin clearance, creatinine clearance, and
Cockcroft-Gault formula, in our sample of families of
African descent with at least two hypertensive siblings,
confirm the familial aggregation of this trait and justify
further analyses aimed at discovering genetic determi-
nants of GFR.
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